{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:33:27Z","timestamp":1791232407479,"version":"4.1.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T00:00:00Z","timestamp":1582243200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T00:00:00Z","timestamp":1582243200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"University of L\u00fcbeck, Germany","award":["Junior Research Grant"],"award-info":[{"award-number":["Junior Research Grant"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Whether or not double J (DJ) stenting during transurethral resection of a bladder tumour (TURBT) harms patients with regard to possible metachronous upper urinary tract urothelial cancer (UUTUC) development remains controversial. This study evaluated the impact of DJ compared to nephrostomy placement during TURBT for bladder cancer (BCa) on the incidence of metachronous UUTUCs.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>We retrospectively analysed 637 patients who underwent TURBT in our department between 2008 and 2016. BCa, UUTUC and urinary drainage data (retrograde\/anterograde DJ and percutaneous nephrostomy) were assessed, along with the prevalence of hydronephrosis, and mortality. Chi-square and Fisher\u2019s exact test was performed for univariate analyses. Survival analysis was performed by the Kaplan-Meier method and log-rank tests.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>UUTUC was noted in 28 out of 637 patients (4.4%), whereas only eight (1.3%) developed it metachronously to BCa. Out of these, four patients received DJ stents, while four patients received no urinary drainage of the upper urinary tract. Placement of urinary drainage significantly correlated with UUTUC (50.0% vs. 17.9%; <jats:italic>p<\/jats:italic>\u2009=\u20090.041). DJ stenting significantly correlated with UUTUC (50.0% vs. 11%; <jats:italic>p<\/jats:italic>\u2009&lt;\u2009\u00a00.01), while no patient with a nephrostomy tube developed UUTUC. UUTUC-free survival rates were significantly lower for patients with DJ stents than for all other patients (<jats:italic>p<\/jats:italic>\u2009=\u20090.001). Patients with or without DJ stents had similar overall survival (OS) rates (<jats:italic>p<\/jats:italic>\u2009=\u20090.73), whereas patients with nephrostomy tubes had significantly lower OS rates than all other patients (<jats:italic>p<\/jats:italic>\u2009&lt;\u2009\u00a00.001).<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Patients with DJ stenting during TURBT for BCa might have an increased risk of developing metachronous UUTUC. This study indicated advantages in placing nephrostomy tubes rather than DJ stents; however, confirmation requires investigation of a larger cohort. Even so, the increased mortality rate in the nephrostomy group reflected hydronephrosis as an unfavourable prognostic factor.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12885-020-6620-2","type":"journal-article","created":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T14:03:43Z","timestamp":1582293823000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Impact of double J stenting or nephrostomy placement during transurethral resection of bladder tumour on the incidence of metachronous upper urinary tract urothelial cancer"],"prefix":"10.1186","volume":"20","author":[{"given":"Marie C.","family":"Hupe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Dormayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Ozimek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian P.","family":"Struck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin J. P.","family":"Hennig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Klee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph A. J.","family":"von Klot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus A.","family":"Kuczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel S.","family":"Merseburger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario W.","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,21]]},"reference":[{"key":"6620_CR1","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.eururo.2017.07.036","volume":"73","author":"M Roupr\u00eat","year":"2018","unstructured":"Roupr\u00eat M, Babjuk M, Comp\u00e9rat E, et al. European Association of Urology guidelines on upper urinary tract urothelial carcinoma: 2017 update. Eur Urol. 2018;73:111\u201322.","journal-title":"Eur Urol"},{"key":"6620_CR2","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s00345-012-0877-2","volume":"31","author":"M Cosentino","year":"2013","unstructured":"Cosentino M, Palou J, Gaya JM, Breda A, Rodriguez-Faba O, Villavicencio-Mavrich H. Upper urinary tract urothelial cell carcinoma: location as a predictive factor for concomitant bladder carcinoma. World J Urol. 2013;31:141\u20135.","journal-title":"World J Urol"},{"key":"6620_CR3","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/j.1442-2042.2010.02539.x","volume":"17","author":"E Takaoka","year":"2010","unstructured":"Takaoka E, Hinotsu S, Joraku A, et al. Pattern of intravesical recurrence after surgical treatment for urothelial cancer of the upper urinary tract: a single institutional retrospective long-term follow-up study. Int J Urol. 2010;17:623\u20138.","journal-title":"Int J Urol"},{"key":"6620_CR4","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1097\/01.ju.0000169424.79702.6d","volume":"174","author":"J Palou","year":"2005","unstructured":"Palou J, Rodr\u00edguez-Rubio F, Huguet J, et al. Multivariate analysis of clinical parameters of synchronous primary superficial bladder cancer and upper urinary tract tumor. J Urol. 2005;174:859\u201361 discussion 861.","journal-title":"J Urol"},{"key":"6620_CR5","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s00345-012-0905-2","volume":"31","author":"N Perlis","year":"2013","unstructured":"Perlis N, Turker P, Bostrom PJ, et al. Upper urinary tract and urethral recurrences following radical cystectomy: review of risk factors and outcomes between centres with different follow-up protocols. World J Urol. 2013;31:161\u20137.","journal-title":"World J Urol"},{"key":"6620_CR6","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1016\/j.juro.2012.08.017","volume":"188","author":"S Picozzi","year":"2012","unstructured":"Picozzi S, Ricci C, Gaeta M, et al. Upper urinary tract recurrence following radical cystectomy for bladder cancer: a meta-analysis on 13,185 patients. J Urol. 2012;188:2046\u201354.","journal-title":"J Urol"},{"key":"6620_CR7","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.juro.2009.08.158","volume":"183","author":"MK Tollefson","year":"2010","unstructured":"Tollefson MK, Blute ML, Farmer SA, Frank I. Significance of distal ureteral margin at radical cystectomy for urothelial carcinoma. J Urol. 2010;183:81\u20136.","journal-title":"J Urol"},{"key":"6620_CR8","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1016\/j.juro.2009.08.046","volume":"182","author":"BG Volkmer","year":"2009","unstructured":"Volkmer BG, Schnoeller T, Kuefer R, Gust K, Finter F, Hautmann RE. Upper urinary tract recurrence after radical cystectomy for bladder cancer--who is at risk? J Urol. 2009;182:2632\u20137.","journal-title":"J Urol"},{"key":"6620_CR9","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/j.juro.2017.06.020","volume":"198","author":"B Kiss","year":"2017","unstructured":"Kiss B, Furrer MA, Wuethrich PY, Burkhard FC, Thalmann GN, Roth B. Stenting prior to cystectomy is an independent risk factor for upper urinary tract recurrence. J Urol. 2017;198:1263\u20138.","journal-title":"J Urol"},{"key":"6620_CR10","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1159\/000049793","volume":"40","author":"J Huguet-P\u00e9rez","year":"2001","unstructured":"Huguet-P\u00e9rez J, Palou J, Mill\u00e1n-Rodr\u00edguez F, Salvador-Bayarri J, Villavicencio-Mavrich H, Vicente-Rodr\u00edguez J. Upper tract transitional cell carcinoma following cystectomy for bladder cancer. Eur Urol. 2001;40:318\u201323.","journal-title":"Eur Urol"},{"key":"6620_CR11","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/j.juro.2008.10.168","volume":"181","author":"JL Wright","year":"2009","unstructured":"Wright JL, Hotaling J, Porter MP. Predictors of upper tract urothelial cell carcinoma after primary bladder cancer: a population based analysis. J Urol. 2009;181:1035\u20139 discussion 1039.","journal-title":"J Urol"},{"key":"6620_CR12","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1111\/j.1442-2042.2006.01385.x","volume":"13","author":"EC Chou","year":"2006","unstructured":"Chou EC, Lin AT, Chen KK, Chang LS. Superficial transitional cell carcinoma of the ureteral orifice: higher risk of developing subsequent upper urinary tract tumors. Int J Urol. 2006;13:682\u20135.","journal-title":"Int J Urol"},{"key":"6620_CR13","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.juro.2007.05.054","volume":"178","author":"RT Divrik","year":"2007","unstructured":"Divrik RT, Sahin A, Altok M, Unl\u00fc N, Zorlu F. The frequency of hydronephrosis at initial diagnosis and its effect on recurrence and progression in patients with superficial bladder cancer. J Urol. 2007;178:802\u20136 discussion 806.","journal-title":"J Urol"},{"key":"6620_CR14","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1159\/000321008","volume":"86","author":"T Hofner","year":"2011","unstructured":"Hofner T, Haferkamp A, Knapp L, et al. Preoperative hydronephrosis predicts advanced bladder cancer but is not an independent factor for cancer-specific survival after radical cystectomy. Urol Int. 2011;86:25\u201330.","journal-title":"Urol Int"},{"key":"6620_CR15","doi-asserted-by":"publisher","first-page":"158","DOI":"10.3389\/fonc.2019.00158","volume":"9","author":"JJ Oh","year":"2019","unstructured":"Oh JJ, Byun SS, Jeong CW, Kwak C, Kim HH, Ku JH. Association between preoperative hydronephrosis and prognosis after radical cystectomy among patients with bladder cancer: a systemic review and meta-analysis. Front Oncol. 2019;9:158.","journal-title":"Front Oncol"},{"key":"6620_CR16","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1016\/j.juro.2012.08.006","volume":"188","author":"R Mano","year":"2012","unstructured":"Mano R, Shoshany O, Baniel J, Yossepowitch O. Resection of ureteral orifice during transurethral resection of bladder tumor: functional and oncologic implications. J Urol. 2012;188:2129\u201333.","journal-title":"J Urol"},{"key":"6620_CR17","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1590\/s1677-5538.ibju.2017.0218","volume":"43","author":"M Altok","year":"2017","unstructured":"Altok M, Sahin AF, Gokce MI, Ekin GR, Divrik RT. Ureteral orifice involvement by urothelial carcinoma: long term oncologic and functional outcomes. Int Braz J Urol. 2017;43:1052\u20139.","journal-title":"Int Braz J Urol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-6620-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-020-6620-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-6620-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,21]],"date-time":"2021-02-21T00:48:01Z","timestamp":1613868481000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-020-6620-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,21]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["6620"],"URL":"https:\/\/doi.org\/10.1186\/s12885-020-6620-2","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,21]]},"assertion":[{"value":"13 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval was obtained from the local ethics committee at the University of Luebeck (17-354A9). The need for consent was waived by the ethics committee.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"140"}}